Problems in deceptive medical procedures: an ethical and legal analysis of the administration of placebos

The use of placebos in therapy or research poses ethical questions. What are the benefits and the costs in ethical terms of condoning deception of the patient or subject? What does the deception mean for the patient's or subject's right to give informed consent to his treatment? Doctors ar...

Full description

Saved in:  
Bibliographic Details
Main Author: Simmons, Beth (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: BMJ Publ. 1978
In: Journal of medical ethics
Year: 1978, Volume: 4, Issue: 4, Pages: 172-181
Online Access: Volltext (JSTOR)
Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000naa a22000002 4500
001 1816110345
003 DE-627
005 20220908053202.0
007 cr uuu---uuuuu
008 220908s1978 xx |||||o 00| ||eng c
024 7 |a 10.1136/jme.4.4.172  |2 doi 
035 |a (DE-627)1816110345 
035 |a (DE-599)KXP1816110345 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Simmons, Beth  |e VerfasserIn  |4 aut 
245 1 0 |a Problems in deceptive medical procedures: an ethical and legal analysis of the administration of placebos 
264 1 |c 1978 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a The use of placebos in therapy or research poses ethical questions. What are the benefits and the costs in ethical terms of condoning deception of the patient or subject? What does the deception mean for the patient's or subject's right to give informed consent to his treatment? Doctors are rightly expected to disclose to their patient facts which would in their judgement best enable him to give informed consent to treatment. On occasion, the degree of this disclosure may be limited by the need to avoid hazarding the success of treatment of an unstable patient whose condition threatens his life, but doctors should have no right to withhold information just to prevent a patient refusing consent to therapy. No such limitation should apply in experiments where full disclosure must operate to enable the subject to give his informed consent. The potential medical benefits for the patient of placebo therapy have to be weighed against all the ethical costs of the deception and dishonesty involved, including the longer term repercussions on doctor/patient trust: similar ethical costs may arise in experiments involving the use of placebos without disclosure of this as a possibility to the subject. Deception is ethically degrading to both parties not only being a breach of trust, but denying the moral autonomy of the patient or subject to make his own choice. The writer concludes that placebos should be used only with full disclosure and consent whether in therapy or in research, and that this need not impede the success of either. 
601 |a Problem 
601 |a Administration 
601 |a Placebo 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 4(1978), 4, Seite 172-181  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnns 
773 1 8 |g volume:4  |g year:1978  |g number:4  |g pages:172-181 
856 |3 Volltext  |u http://www.jstor.org/stable/27715739  |x JSTOR 
856 |u https://europepmc.org/articles/pmc1154680?pdf=render  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h repository [oa repository (via OAI-PMH doi match)] 
856 4 0 |u https://doi.org/10.1136/jme.4.4.172  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://jme.bmj.com/content/4/4/172.abstract  |x Verlag  |z kostenfrei  |3 Volltext 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4185562195 
LOK |0 003 DE-627 
LOK |0 004 1816110345 
LOK |0 005 20220908053202 
LOK |0 008 220908||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-08-02#2F39A49916485CD0B815851353F3969A01578475 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 866   |x JSTOR#http://www.jstor.org/stable/27715739 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw